Technical limitations in detection of gastroesophageal reflux in neonates

Juliann M Di Fiore1, Marina Arko, Kim Churbock

  • 1Division of Neonatology, Rainbow Babies and Children's Hospital, Cleveland, OH 44106, USA. jmd3@case.edu

Insights

Many acid reflux events are missed by multiple intraluminal impedance (MII) monitoring, especially in preterm infants. Delayed esophageal clearance may explain these pH-only reflux events.

Area of Science:

  • Gastroenterology
  • Pediatric Medicine
  • Diagnostic Technology

Background:

  • Acid reflux is a common concern in infants, particularly preterm infants.
  • Multiple intraluminal impedance (MII) monitoring is a standard tool for detecting gastroesophageal reflux.
  • pH monitoring complements MII but can detect events not identified by MII.

Purpose of the Study:

  • To investigate the incidence of acid reflux events detected by pH monitoring but missed by MII.
  • To explore the reasons for MII's failure to detect these pH-only events.
  • To identify factors associated with these missed reflux events in infants.

Main Methods:

  • Studied 80 preterm and 39 term infants with documented pH-only reflux events.
  • Classified MII detection failures: scoring criteria, air bolus, artifact, or no impedance change.
  • Analyzed events with no impedance change for indicators like low impedance or preceding reflux.

Main Results:

  • 59% of pH-detected acid reflux events were not identified by MII.
  • pH-only events were more frequent in preterm infants (54%) than term infants (42%).
  • The majority of missed events (64%) showed no impedance change, often linked to transient refluxate or preceding events.

Conclusions:

  • A significant proportion of acid reflux events are missed by MII, particularly in preterm infants.
  • Delayed esophageal fluid clearance is hypothesized as the primary reason for these discrepancies.
  • Findings highlight limitations of MII and suggest underlying physiological differences in immature infants.
Abstract

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...